PMC:7534795 / 110834-111134 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T61","span":{"begin":82,"end":90},"obj":"Body_part"},{"id":"T62","span":{"begin":163,"end":171},"obj":"Body_part"}],"attributes":[{"id":"A61","pred":"fma_id","subj":"T61","obj":"http://purl.org/sig/ont/fma/fma62851"},{"id":"A62","pred":"fma_id","subj":"T62","obj":"http://purl.org/sig/ont/fma/fma63891"}],"text":"N-3 PUFAs contain polar lipids that exhibit potent antithrombotic effects against platelet-activating factor and other prothrombotic pathways, including thrombin, collagen, and adenosine diphosphate (Lordan et al., 2020; Tsoupras et al., 2019; Tsoupras, O'Keeffe, Lordan, Redfern, \u0026 Zabetakis, 2019)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T126","span":{"begin":91,"end":101},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T127","span":{"begin":163,"end":171},"obj":"http://purl.obolibrary.org/obo/CHEBI_3815"}],"text":"N-3 PUFAs contain polar lipids that exhibit potent antithrombotic effects against platelet-activating factor and other prothrombotic pathways, including thrombin, collagen, and adenosine diphosphate (Lordan et al., 2020; Tsoupras et al., 2019; Tsoupras, O'Keeffe, Lordan, Redfern, \u0026 Zabetakis, 2019)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T40880","span":{"begin":4,"end":9},"obj":"Chemical"},{"id":"T56258","span":{"begin":24,"end":30},"obj":"Chemical"},{"id":"T81371","span":{"begin":82,"end":108},"obj":"Chemical"},{"id":"T47565","span":{"begin":177,"end":186},"obj":"Chemical"},{"id":"T76873","span":{"begin":187,"end":198},"obj":"Chemical"}],"attributes":[{"id":"A93928","pred":"chebi_id","subj":"T40880","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"},{"id":"A27839","pred":"chebi_id","subj":"T56258","obj":"http://purl.obolibrary.org/obo/CHEBI_18059"},{"id":"A37424","pred":"chebi_id","subj":"T81371","obj":"http://purl.obolibrary.org/obo/CHEBI_36707"},{"id":"A48140","pred":"chebi_id","subj":"T81371","obj":"http://purl.obolibrary.org/obo/CHEBI_44811"},{"id":"A63095","pred":"chebi_id","subj":"T81371","obj":"http://purl.obolibrary.org/obo/CHEBI_52450"},{"id":"A69244","pred":"chebi_id","subj":"T47565","obj":"http://purl.obolibrary.org/obo/CHEBI_16335"},{"id":"A46647","pred":"chebi_id","subj":"T76873","obj":"http://purl.obolibrary.org/obo/CHEBI_18361"},{"id":"A89803","pred":"chebi_id","subj":"T76873","obj":"http://purl.obolibrary.org/obo/CHEBI_33019"}],"text":"N-3 PUFAs contain polar lipids that exhibit potent antithrombotic effects against platelet-activating factor and other prothrombotic pathways, including thrombin, collagen, and adenosine diphosphate (Lordan et al., 2020; Tsoupras et al., 2019; Tsoupras, O'Keeffe, Lordan, Redfern, \u0026 Zabetakis, 2019)."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T28","span":{"begin":82,"end":101},"obj":"http://purl.obolibrary.org/obo/GO_0030168"}],"text":"N-3 PUFAs contain polar lipids that exhibit potent antithrombotic effects against platelet-activating factor and other prothrombotic pathways, including thrombin, collagen, and adenosine diphosphate (Lordan et al., 2020; Tsoupras et al., 2019; Tsoupras, O'Keeffe, Lordan, Redfern, \u0026 Zabetakis, 2019)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T683","span":{"begin":0,"end":300},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"N-3 PUFAs contain polar lipids that exhibit potent antithrombotic effects against platelet-activating factor and other prothrombotic pathways, including thrombin, collagen, and adenosine diphosphate (Lordan et al., 2020; Tsoupras et al., 2019; Tsoupras, O'Keeffe, Lordan, Redfern, \u0026 Zabetakis, 2019)."}

{"project":"2_test","denotations":[{"id":"33031856-32270798-84039142","span":{"begin":215,"end":219},"obj":"32270798"}],"text":"N-3 PUFAs contain polar lipids that exhibit potent antithrombotic effects against platelet-activating factor and other prothrombotic pathways, including thrombin, collagen, and adenosine diphosphate (Lordan et al., 2020; Tsoupras et al., 2019; Tsoupras, O'Keeffe, Lordan, Redfern, \u0026 Zabetakis, 2019)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3149","span":{"begin":153,"end":161},"obj":"Gene"},{"id":"3152","span":{"begin":177,"end":186},"obj":"Chemical"}],"attributes":[{"id":"A3149","pred":"tao:has_database_id","subj":"3149","obj":"Gene:2147"},{"id":"A3152","pred":"tao:has_database_id","subj":"3152","obj":"MESH:D000241"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"N-3 PUFAs contain polar lipids that exhibit potent antithrombotic effects against platelet-activating factor and other prothrombotic pathways, including thrombin, collagen, and adenosine diphosphate (Lordan et al., 2020; Tsoupras et al., 2019; Tsoupras, O'Keeffe, Lordan, Redfern, \u0026 Zabetakis, 2019)."}